average weight loss first week tirzepatide Where Do You Lose on Tirzepatide? Can Tirzepatide Help You Lose

Glucagon-like peptide-1 receptor agonists and risk for gastroesophageal reflux disease in patients with type 2 diabetes: a population-based cohort study

CagriSema is filed T2D evidence : Tirzepatide has more extensive T2D trial data GI tolerability : CagriSema has higher overall GI event rates Conclusion# CagriSema and tirzepatide represent different strategies to the same goal: surpassing GLP-1-only weight loss

Ipamorelin is more selective and does not appreciably raise cortisol or prolactin, which makes it the most commonly chosen GH secretagogue in current research literature

Among individuals with obesity and type 2 diabetes, both medications were associated with lower hazards of anxiety disorders, broadly defined cognitive deficits, mood disorders, and depression